Skip to content

Effect of COVID-19 on hormone and semen parameter in male COVID-19 patients.

Effect of COVID-19 on hormone and semen parameter in male COVID-19 patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20210617006
Enrollment
116
Registered
2021-06-17
Start date
2021-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Serum hormonal level and semen parameter in COVID-19 patients at 3, 6, 12 months after infection. COVID-19, Male serum hormone, Semen parameter, Chronic COVID syndrome, male fertility

Interventions

Male patients with history of confirmed COVID-19 infection.,Healthy men, without prior history of COVID-19 infection. For match-pair analysis
Other,Other
COVID-19 Patients,Healthy volunteer

Sponsors

None listed

Eligibility

Sex/Gender
Male
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Male COVID-19 patients hospitalized at KCMH 2. Age 18 y or older 3. Healthy male volunteer, with no previous history of COVID-19 infection. 4. Patients not require additional oxygen supplementation during admission

Exclusion criteria

Exclusion criteria: Male with 1. History of infertility 2. History of testicular trauma, testicular surgery, testicular infection. 3. History of mumps 4. History of testicular tumor or active other malignancy 5. History of cryptorchidism

Design outcomes

Primary

MeasureTime frame
Serum testosterone level at 2wk, 3, 6, 12 mo after infection Serum testosterone level, nmol/L,Serum FSH level at 2wk, 3, 6, 12 mo after infection Serum FSH level, IU/L,Serum LH level at 2wk, 3, 6, 12 mo after infection Serum LH level, IU/L,Semen parameter at 3, 12 mo after infection According to WHO laboratory manual for the examination and processing of human semen, 5th edition,Serum AST level at 2wk after infection U/L,Serum ALT at 2wk after infection U/L,ALP at 2wk after infection U/L,Serum albumin level at 2wk after infection g/L,Serum Globulin level at 2wk after infection g/L,Serum Total bilirubin at 2wk after infection mg/dL,Serum Direct bilirubin at 2wk after infection mg/dL

Secondary

MeasureTime frame
IIEF5 Score at 2wk, 3, 6, 12 mo after infection 4

Countries

Thailand

Contacts

Public ContactPrarch Boonkerd

Division of Urology, Department of Surgery, Faculty of medicine, Chulalongkorn University

prarch.bo@cpird.in.th0853975156

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026